Novavax | NVAX - 販売および管理費





販売および管理費 変化する 日付
Adma Biologics USD 26.74M 6.55M 2026-03
Agenus USD 6.21M 4.34M 2026-03
AstraZeneca USD 5.8B 735M 2026-06
BioCryst Pharmaceuticals USD 63.98M 31.8M 2026-06
Cassava Sciences USD 3.89M 2.77M 2026-03
Geron USD 35.42M 6.24M 2026-03
GlaxoSmithKline GBP 2.19B 75M 2026-06
MannKind USD 58.3M 4.22M 2026-06
Merck USD 2.89B 219M 2026-06
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Moderna USD 216M 43M 2026-06
Novartis USD 3.14B 296M 2026-03
Novavax USD 25.53M 1.34M 2025-12
Pfizer USD 3.41B 496M 2026-06
Sanofi EUR 2.63B 307M 2026-06
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
TG Therapeutics USD 62.32M 10.82M 2026-06